Current Report Filing (8-k)
February 18 2021 - 1:25PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities and Exchange Act of 1934
Date
of Report (Date of earliest event reported): February 11, 2021
SURGEPAYS,
INC.
(Exact
name of Registrant as specified in its charter)
Nevada
|
|
000-52522
|
|
98-0550352
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification
No.)
|
3124
Brother Blvd, Suite 104
Bartlett
TN 38133
(Address
of principal executive offices, including zip code)
901-302-9587
(Registrant’s
telephone number, including area code)
Check
the appropriate box below if the 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under
any of the following provisions:
[ ]
|
Written
communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).
|
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of each exchange on which registered
|
None
|
|
None
|
|
None
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR
§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging
growth company [ ]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Item
5.02
|
Departure
of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
|
On
February 11, 2021, both Carter Matzinger and David Ansani tendered their resignations from their positions as members of the Board
of Directors (the “Board”) of SurgePays, Inc (the “Company”), effective immediately. Neither Mr. Matzinger’s
nor Mr. Ansani’s resignations were due to any disagreements with the Company on any of the Company’s operations, policies
or practices. Mr. Matzinger continues to serve as the Chief Strategic Officer of the Company and Mr. Ansani continues to serve
as the Chief Administrative Officer of the Company.
Following
Mr. Matzinger and Mr. Ansani’s resignations, the Company is seeking to appoint two new independent directors to the Board.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned, hereunto duly authorized.
|
SURGEPAYS,
INC.
|
|
|
|
Date:
February 18, 2021
|
By:
|
/s/
Brian Cox
|
|
Name:
|
Brian
Cox
|
|
Title:
|
Chief
Executive Officer
|